Source: Annual Congress 2013 –COPD and infections
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Pichavant, G. Rémy, G. Kervoaze, R. Sharan, E. Vilain, P. Gosset (Lille, France). Alteration of the immune response to streptococcus pneumoniae during COPD exacerbation in mice. Eur Respir J 2013; 42: Suppl. 57, 3317

Member's Comments

No comment yet.

Related content which might interest you: Alteration of the immune response to nontypeable haemophilus influenzae (NTHI) during COPD exacerbation in mice Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Chronic pulmonary infection with streptococcus pneumoniae during ovalbumin allergic inflammation Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Adenovirus-specific immunoglobulin G maturation in acute exacerbations of COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 LATE-BREAKING ABSTRACT: IL33 drives humoral and cellular immune response in influenza-induced severe exacerbation of experimental asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Establishment of a murine asthma exacerbation model by combining OVA exposure with either RSV or influenza infection Source: International Congress 2016 – Immune responses in the lung Year: 2016 IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice Source: International Congress 2016 – Immune responses in the lung Year: 2016 Identification of nasal virus infection in patients with COPD exacerbations Source: International Congress 2014 – COPD: points to ponder Year: 2014 Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma Source: International Congress 2016 – Immune responses in the lung Year: 2016 Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Increased total, secretory and NTHi-specific IgA in the COPD airway Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: The Guangzhou COPD exacerbation study: relationship of exacerbations with viral infections and soluble biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 A peripheral HRV-16-driven fingerprint is enriched in severe asthma patients in absence of an active exacerbation Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Etiological structure from sputum of patients with exacerbation of COPD Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 The role of IFN-γ in severe COPD patients with anamnestic viral-induced exacerbations before and after roflumilast treatment Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Assesment of the effects of tocilizumab, adalimumab and steroid in LPS induced acute lung inflammation Source: International Congress 2016 – Airway response to infection Year: 2016 Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model) Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014